Myasthenia gravis: an overview.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D009469:Neuromuscular Junction / Q000502:physiology / Q000648:ultrastructure; D009801:Oculomotor Muscles; D011247:Pregnancy; D013945:Thymoma / Q000150:complications; D013953:Thymus Neoplasms / Q000150:complications; D014786:Vision Disorders / Q000209:etiology
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents